Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CytomX Therapeutics, Inc. (CTMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/25/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/08/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/03/2022 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 8.9% stake in CytomX Therapeutics, Inc.
12/08/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/29/2021 SC 13G RA CAPITAL MANAGEMENT, L.P. reports a 5.8% stake in CYTOMX THERAPEUTICS, INC.
01/26/2021 SC 13G Point72 Asset Management, L.P. reports a 9.1% stake in CytomX Therapeutics, Inc.
03/06/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/11/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/31/2020 SC 13G VICTORY CAPITAL MANAGEMENT INC reports a 6.2% stake in CYTOMX THERAPEUTICS INC
02/14/2019 SC 13G PRICE T ROWE ASSOCIATES INC reports a 9% stake in CytomX Therapeutics, Inc.
02/12/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/01/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/18/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/29/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/11/2016 SC 13G Canaan IX L.P. reports a 13.6% stake in CytomX Therapeutics, Inc.
02/10/2016 SC 13G CytomX Therapeutics, Inc. reports a 24.1% stake in CytomX Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy